Bdr Pharma News Today

India Business News: BDR Pharma launches BDENZA (Enzalutamide), the world's first oral solution for prostate cancer management. BDENZA is priced at Rs 27,000 for 150mL, of

The deal is for two apartments in Raheja Artesia, where Ipsita Dasgupta, the former Apple executive, had purchased flat for Rs 22.52 crore.

The performance in terms of stamp duty collection led by the heightened activity in premium and mid-income housing segments have also pushed the state exchequers revenue higher for several months. In the first 10 months of the current year, the state government has already fetched over Rs 9,220 crore through stamp duty collection surpassing the all-time high of over Rs 8,893 crore recorded in 2022.

Mumbai: The performance in terms of stamp duty collection led by the heightened activity in premium and mid-income housing segments have also pushed the state exchequer’s revenue higher for several months.

Apalutamide plus ADT (androgen-deprivation therapy) arm shows a significant decrease in the risk of disease progression and reduces risk of mortality by 35% amongst Non-Metastatic Castration resistant...

Sugmadex is set to be the game changer in the segment of reversal agents in the modern day surgery

BDR Pharma partners with Varenyam Healthcare

BDR Pharma company has introduced new medication, under the brand name BDENZA 160mg, at Rs 6,300 for a strip of seven tablets.

Patients will have one capsule to ensure better efficacy

The tie-up is a licensing arrangement where production is by BDR Pharma and marketing, selling, promotion, distribution is by Mankind Pharma